In conclusion, CAV1 is comprehensively involved in the regulation of cell adhesion, NK cell stimulation, autophagy, ROS generation, redox homeostasis, and glutamine transport and metabolism in MM cells, and thus serves as a potent therapeutic target for enhancing chemotherapy and immunotherapy for MM. This evidence concerns the gene CAV1 and Miyoshi myopathy.